Global Markets for Aesthetic Products
142 Pages |
71 Exhibits |
Forecasts Through 2017
Order individually or subscribe to Medtech Pro and get a complete intel platform.
Overview
The global market for the aesthetic devices analyzed in this report was valued at nearly $4.3 billion in 2011. The market has fluctuated in recent years and saw declines in 2009. The year 2011, however, was marked by higher sales volumes than in historical years, largely due to the growing popularity of aesthetic procedures as a means to improve appearance or restore a youthful look as well as the growing availability of non-surgical treatments. The emergence of markets in Asia and South America has also helped to boost sales. These factors will contribute to higher sales volumes throughout the forecast period, and in 2017, the global market is expected to reach a value of $7.8 billion.This report provides a deep and detailed analysis of: implants, dermal fillers, neuromodulators, and lasers, light-based systems, and other energy-based devices.
Find out which segments will account for the greatest share, as well as which regions will exceed a 14% CAGR, through 2017.
Companies Covered
Aesthetic SciencesAllergan
Alma Lasers
Angiodynamics
Anteis
Applisonix
biolitec
Chromogenex
Contura International
Covidien
Cutera
Cynosure
Dornier MedTech
Eclipse Aesthetics
El. En
EndyMed
Energist
Establishment Labs
General Project
IRIDEX Aesthetics
Jeisys
LifeCell
Lumenis
Lutronic
Medicis Pharmaceutical
Mentor Worldwide (Johnson & Johnson)
Merz Aesthetics
New Star Lasers
Osyris Medical
Palomar Medical Technologies
PhotoMedex
POLYTECH Health & Aesthetics
Rofil Medical Aesthetics
sanofi-aventis
Sciton
Silimed
Solta Medical
Spectrum Designs Medical
Suneva Medical
Surgimedix
Syneron Medical
TRIA Beauty
Ultrashape
Vascular Solutions
ZELTIQ Aesthetics
Table of Contents
1. EXECUTIVE SUMMARY
1.1 Aesthetic Implants
1.2 Dermal Fillers & Neuromodulators
1.3 Lasers, Light-Based Systems, and Other Energy-Based Devices
Exhibit 1-1: The Global Market for Aesthetic Devices by Product Type from 2010-2017
Exhibit 1-2: The Global Market for Aesthetic Devices by Region from 2010-2017
Exhibit 1-3: The Global Market Forecast for Aesthetic Implants by Type from 2010-2017
Exhibit 1-4: The Global Market Forecast for Aesthetic Implants by Region from 2010-2017
Exhibit 1-5: The Global Market Forecast for Dermal Fillers and Neuromodulators from 2010-2017
Exhibit 1-6: The Global Market Forecast for Dermal Fillers and Neuromodulators by Region from 2010-2017
Exhibit 1-7: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
Exhibit 1-8: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Region from 2010-2017
2. AESTHETIC IMPLANTS
2.1 Types of Products
2.1.1 Breast Implants
2.1.2 Facial Implants
2.1.3 Other Bodily Implants
2.1.4 Tissue Expanders for Breast Reconstructions
2.2 Procedure Forecasts and Market Analyses
2.2.1 U.S. Procedure Forecasts and Market Analyses
2.2.1.1 Breast Augmentation
2.2.1.2 Facial Implants
2.2.1.3 Other Bodily Implants
2.2.1.4 Breast Reconstruction
2.2.1.5 U.S. Supplier Shares
2.2.2 European Procedure Forecasts and Market Analyses
2.2.2.1 Breast Augmentation
2.2.2.2 Facial Implants
2.2.2.3 Other Bodily Implants
2.2.2.4 Breast Reconstruction
2.2.3 Procedure Forecasts and Market Analyses for Countries in Asia-Pacific and the Rest-of-the-World
2.2.3.1 Breast Augmentation
2.2.3.2 Facial Implants
2.2.3.3 Other Bodily Implants
2.2.3.4 Breast Reconstruction
2.2.4 OUS Supplier Shares
Exhibit 2-1: Types of Aesthetic Implants
Exhibit 2-2: Selected Aesthetic Implants in 2012
Exhibit 2-3: The Global Market Forecast for Aesthetic Implants from 2010-2017
Exhibit 2-4: The U.S. Market Forecast for Aesthetic Implants from 2010-2017
Exhibit 2-5: The U.S. Market Forecast for Aesthetic Implants by Type from 2010-2017
Exhibit 2-6: The U.S. Market Forecast for Breast Augmentation from 2010-2017 2-14
Exhibit 2-7: The U.S. Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017
Exhibit 2-8: The U.S. Market Forecast for Facial Implants from 2010-2017
Exhibit 2-9: The U.S. Market Forecast for Other Bodily Implants from 2010-2017
Exhibit 2-10: The U.S. Market Forecast for Breast Reconstructions from 2010-2017
Exhibit 2-11: U.S. Supplier Shares in 2010 and 2011
Exhibit 2-12: The European Market Forecast for Aesthetic Implants from 2010-2017
Exhibit 2-13: The European Market Forecast for Aesthetic Implants by Type from 2010-2017
Exhibit 2-14: The European Market Forecast for Breast Augmentation from 2010-2017
Exhibit 2-15: The European Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017
Exhibit 2-16: The European Market Forecast for Facial Implants from 2010-2017
Exhibit 2-17: The European Market Forecast for Other Bodily Implants from 2010-2017
Exhibit 2-18: The European Market Forecast for Breast Reconstructions from 2010-2017
Exhibit 2-19: The AP & ROW Market Forecast for Aesthetic Implants from 2010-2017
Exhibit 2-20: The AP & ROW Market Forecast for Aesthetic Implants by Type from 2010-2017
Exhibit 2-21: The AP & ROW Market Forecast for Breast Augmentation from 2010-2017
Exhibit 2-22: The AP & ROW Market Forecast for Breast Augmentation, by Implant Type, from 2010-2017
Exhibit 2-24: The AP & ROW Market Forecast for Other Bodily Implants from 2010-2017
Exhibit 2-25: The AP & ROW Market Forecast for Breast Reconstructions from 2010-2017
Exhibit 2-26: OUS Supplier Shares in 2010 and 2011
3. DERMAL FILLERS & NEUROMODULATORS
3.1 Product Types
3.2 Procedure Forecasts and Market Analyses
3.2.1 U.S. Procedure Forecasts and Market Analyses
3.2.1.1 Dermal Fillers
3.2.1.2 Neuromodulators
3.2.1.3 U.S. Supplier Shares
3.2.2 European Procedure Forecasts and Market Analyses
3.2.2.1 Dermal Fillers
3.2.2.2 Neuromodulators
3.2.3 Procedure Forecasts and Market Analyses for Countries in Asia-Pacific and the Rest-of-the-World
3.2.3.1 Dermal Fillers
3.2.3.2 Neuromodulators
3.2.4 OUS Supplier Shares
Exhibit 3-1: Dermal Fillers & Neuromodulators
Exhibit 3-2: Advantages & Disadvantages of Dermal Fillers & Neuromodulators
Exhibit 3-3: Selected Dermal Fillers & Neuromodulators in 2012
Exhibit 3-4: The Global Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
Exhibit 3-5: The U.S. Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
Exhibit 3-6: The U.S. Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017
Exhibit 3-7: The U.S. Market Forecast for Dermal Fillers from 2010-2017
Exhibit 3-8: The U.S. Market Forecast for Neuromodulators from 2010-2017
Exhibit 3-9: U.S. Supplier Shares in 2010 and 2011
Exhibit 3-10: The European Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
Exhibit 3-11: The European Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017
Exhibit 3-12: The European Market Forecast for Dermal Fillers from 2010-2017
Exhibit 3-13: The European Market Forecast for Neuromodulators from 2010-2017
Exhibit 3-14: The AP & ROW Market Forecast for Dermal Fillers & Neuromodulators from 2010-2017
Exhibit 3-15: The AP & ROW Market Forecast for Dermal Fillers & Neuromodulators by Type from 2010-2017
Exhibit 3-16: The AP & ROW Market Forecast for Dermal Fillers from 2010-2017
Exhibit 3-17: The AP & ROW Market Forecast for Neuromodulators from 2010-2017
Exhibit 3-18: OUS Supplier Shares in 2010 and 2011
4. LASERS, LIGHT-BASED SYSTEMS, & OTHER ENERGY-BASED DEVICES
4.1 Product Types
4.2 Advantages and Disadvantages of Lasers, Light-Based Systems, and Other Energy-Based Devices for Aesthetic Applications
4.3 Procedure Forecasts and Market Analyses
4.3.1 U.S. Procedure Forecasts and Market Analyses
4.3.1.1 Lasers, Light-Based, and Other Energy-Based Systems
4.3.1.2 Endovenous Vein Ablations
4.3.1.3 U.S. Supplier Shares
4.3.2 OUS Procedure Forecasts and Market Analyses .
4.3.2.1 European Procedure Forecasts and Market Analyses
4.3.2.1.1 Lasers, Light-, and Other Energy-Based Systems
4.3.2.1.2 Endovenous Vein Ablations
4.3.2.2 AP & ROW Procedure Forecasts and Market Analyses
4.3.2.2.1 Lasers, Light-, and Other Energy-Based Systems
4.3.2.2.2 Endovenous Vein Ablations
4.3.2.3 OUS Supplier Shares
Exhibit 4-1: Selected Lasers, Light-Based Systems, and Other Energy-Based Devices in 2012
Exhibit 4-2: Advantages & Disadvantages of Lasers, Light-Based Systems, and Other Energy-Based Devices for Aesthetic Procedures
Exhibit 4-3: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
Exhibit 4-4: The Global Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Geography from 2010-2017
Exhibit 4-5: The U.S. Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
Exhibit 4-6: The U.S. Forecast for Aesthetic Procedures Using Lasers, Light-Based Systems, & Other Energy-Based Devices from 2010-2017
Exhibit 4-7: The U.S. Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; &
Cryolipolysis
Exhibit 4-8: Endovenous Vein Ablations in the U.S. from 2010-2017
Exhibit 4-9: The U.S. Market Forecast for Endovenous Vein Ablations from 2010-2017
Exhibit 4-10: U.S. Supplier Shares in 2010 and 2011
Exhibit 4-11: The European Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
Exhibit 4-12: The European Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; &
Cryolipolysis
Exhibit 4-13: Endovenous Vein Ablations in Europe from 2010-2017
Exhibit 4-14: The European Market Forecast for Endovenous Vein Ablations from 2010-2017
Exhibit 4-15: The AP & ROW Market Forecast for Lasers, Light-Based Systems, and Other Energy-Based Devices by Type from 2010-2017
Exhibit 4-16: The AP & ROW Market Forecast for Lasers, Light-Based, and Other Energy-Based Systems from 2010-2017: Lasers, Light-Based, & Ultrasound; Radiofrequency; &
Cryolipolysis
Exhibit 4-17: Endovenous Vein Ablations in AP & ROW Countries from 2010-2017
Exhibit 4-18: The AP & ROW Market Forecast for Endovenous Vein Ablations from 2010-2017
Exhibit 4-19: OUS Supplier Shares in 2010 and 2011
5. COMPANY PROFILES
5.1 Allergan
5.2 Alma Lasers
5.3 AngioDynamics
5.4 biolitec
5.5 Covidien
5.6 Cutera
5.7 Cynosure
5.8 El. En
5.9 Galderma
5.10 GC Aesthetics
5.11 Lumenis
5.12 Medicis Pharmaceutical
5.13 Mentor Worldwide (Johnson & Johnson)
5.14 Merz Aesthetics
5.15 Palomar Medical Technologies
5.16 PhotoMedex
5.17 sanofi-aventis
5.18 Silimed
5.19 Solta Medical
5.20 Syneron Medical
5.21 ZELTIQ Aesthetics
